The impact of time on the systemic inflammatory response in pneumococcal pneumonia

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Respiratory Journal

• Publication date

  2009-07-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/09031936.00052709PMID 19608588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• UvA-DARE ( Digital Academic Repository ) Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia

  2017cited by this paper
• Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis

  2008cited by this paper
• Systemic Expression of Cytokine Production in Patients with Severe Pneumococcal Pneumonia: Effects of Treatment with a β-Lactam versus a Fluoroquinolone

  2008cited by this paper
• Acute lower respiratory tract infection.

  2008cited by this paper
• Acute lower respiratory tract infection.

  2008cited by this paper
• Prompt antibiotic administration and goal-directed hemodynamic support in patients with severe sepsis and septic shock

  2007cited by this paper
• Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.

  2007cited by this paper
• Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*

  2006cited by this paper
• Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.

  2004cited by this paper
• The pathophysiology and treatment of sepsis.

  2003cited by this paper
• Role of Inflammatory Mediators in Resistance and Susceptibility to Pneumococcal Infection

  2002cited by this paper
• Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia.

  2001cited by this paper
• Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations.

  2001cited by this paper
• Pathogenesis of pneumococcal infection.

  2000cited by this paper
• Pathogenesis of pneumococcal pneumonia.

  1999cited by this paper
• Cytokine Kinetics and Other Host Factors in Response to Pneumococcal Pulmonary Infection in Mice

  1998cited by this paper
• Quality of care, process, and outcomes in elderly patients with pneumonia.

  1997cited by this paper
• Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice

  1997cited by this paper
• A prediction rule to identify low-risk patients with community-acquired pneumonia.

  1997cited by this paper
• Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice.

  1997cited by this paper
• Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor

  1995cited by this paper
• The molecular basis of pneumococcal infection: a hypothesis.

  1995cited by this paper
• Pathogenesis of pneumococcal infection.

  1995cited by this paper
• Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes

  1994cited by this paper
• Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes

  1994cited by this paper
• Pathogenesis of pneumococcal pneumonia.

  1991cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• APACHE II: A severity of disease classification system

  1985cited by this paper
• APACHE II: a severity of disease classification system.

  1985cited by this paper

• Clinical characteristics and diagnostic accuracy of preliminary diagnoses in adults with infections in Danish emergency departments: a multicentre combined cross-sectional and diagnostic study

  2024cites this paper
• Bacterium-like Particles from Corynebacterium pseudodiphtheriticum as Mucosal Adjuvant for the Development of Pneumococcal Vaccines

  2024cites this paper
• Definition, Epidemiology, and Pathogenesis of Severe Community-Acquired Pneumonia

  2024cites this paper
• Acute organ injury and long-term sequelae of severe pneumococcal infections

  2023cites this paper
• Nausea Predicts Bacteremia in Immunocompetent Patients with Pneumococcal Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort

  2023cites this paper
• Cholesterol Microdomain Enhances the Biofilm Eradication of Antibiotic Liposomes

  2022cites this paper
• Biomarker Value in the Diagnosis of Community-Acquired Pneumonia with Concomitant Chronic Heart Failure

  2021cites this paper
• The potential role of interleukin-37 in infectious diseases

  2020cites this paper
• IL-37 Causes Excessive Inflammation and Tissue Damage in Murine Pneumococcal Pneumonia

  2020cites this paper
• Value of biomarkers in the diagnosis of community-acquired pneumonia with concomitant chronic heart failure: a prospective observation study.

  2020cites this paper
• Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis

  2020cites this paper
• Inflammatory mediators and lung abnormalities in HIV: A systematic review

  2019cites this paper
• Analyse der Hyperinflammation im Verlauf der murinen Pneumokokken-Pneumonie unter besonderer Berücksichtigung des Neutrophile-rekrutierenden Chemokins CXCL5

  2019cites this paper
• IL-37 Causes Excessive Inflammation and Tissue Damage in Murine Pneumococcal Pneumonia

  2019cites this paper
• IL-37 Causes Excessive Inflammation and Tissue Damage in Murine Pneumococcal Pneumonia

  2019cites this paper
• IL-37 Causes Excessive Inflammation and Tissue Damage in Murine Pneumococcal Pneumonia

  2019cites this paper
• IL-37 Causes Excessive Inflammation and Tissue Damage in Murine Pneumococcal Pneumonia

  2019cites this paper
• Interleukin-5, interleukin-6, interferon induced protein-10, procalcitonin and C-reactive protein among mechanically ventilated severe community-acquired viral and bacterial pneumonia patients

  2018cites this paper
• Initial Inflammatory Profile in Community‐acquired Pneumonia Depends on Time since Onset of Symptoms

  2018cites this paper
• Inflammatory Mediators Associated With Pressure Ulcer Development in Individuals With Pneumonia After Traumatic Spinal Cord Injury: A Pilot Study.

  2017cites this paper
• IL-37 Causes Excessive Inflammation and Tissue Damage in Murine Pneumococcal Pneumonia

  2017cites this paper
• Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia.

  2016cites this paper
• Bacterial Pulmonary Infection Proteinase-Activated Receptor 1 during Regulation of Neutrophilic Inflammation by Chambers

  2015cites this paper
• Evaluation correlation of Plasma Fibrinogen Concentration with Severity of Acute Community Acquired Pneumonia Disease

  2015cites this paper
• Regulation of Neutrophilic Inflammation by Proteinase-Activated Receptor 1 during Bacterial Pulmonary Infection

  2015cites this paper
• FACTORS ASSOCIATED WITH OCCURRENCE AND EARLY DETECTION OF PRESSURE ULCERS FOLLOWING TRAUMATIC SPINAL CORD INJURY

  2014influential citation
• Therapie der murinen Pneumokokken-Pneumonie mit lytischem Bakteriophagenenzym Cpl-1

  2014cites this paper
• Lymphatic Pump Treatment Enhances the Lymphatic and Immune System and Ameliorates Disease Severity in a Rat Model of Respiratory Infection

  2014cites this paper
• An alternate pathophysiologic paradigm of sepsis and septic shock

  2013cites this paper
• Exploring the role of tumor necrosis factor-stimulated gene 6 in experimental ischaemic stroke

  2013cites this paper
• Systemic immune activation shapes stroke outcome.

  2013cites this paper
• Immunization and vitamin A status as factors modulating an invasive Streptococcus pneumoniae-induced lung and a non-invasive Citrobacter rodentium gut infection in mice

  2012cites this paper
• Caracterización de la respuesta inflamatoria en la neumonía comunitaria grave. Efecto de los corticoides en la contención de dicha respuesta y en el curso evolutivo de la infección

  2012cites this paper
• Factors affecting the development of systemic inflammatory response syndrome in pneumococcal infections

  2011cites this paper
• Interleukin-1 and Stroke: Biomarker, Harbinger of Damage, and Therapeutic Target

  2011cites this paper
• Antimicrobial therapy for life-threatening infections: speed is life.

  2011cites this paper
• Why should we measure bacterial load when treating community-acquired pneumonia?

  2011cites this paper
• Bacteraemic Pneumococcal Pneumonia

  2011cites this paper
• Impact of the Implementation of a Sepsis Protocol for the Management of Fluid-Refractory Septic Shock: A Single-Center, Before-and-After Study

  2011cites this paper
• Emerging drugs for pneumococcal pneumonia

  2011cites this paper
• Of mice and men: innate immunity in pneumococcal pneumonia.

  2010cites this paper
• Factors associated with inflammatory cytokine patterns in community-acquired pneumonia

  2010cites this paper
• The impact of time on the systemic inflammatory response in pneumococcal pneumonia

  2010cites this paper
• Early Antimicrobial Therapy in Severe Sepsis and Septic Shock

  2010cites this paper
• Patient Related Outcome Measures Dovepress Observational Longitudinal Study of Symptom Burden and Time for Recovery from Community- Acquired Pneumonia Reported by Older Adults Surveyed Nationwide Using the Cap Burden of Illness Questionnaire

  year unknowncites this paper